低剂量胸部CT体成分分析是COVID-19不良临床结局的重要预测因素——一项多中心可行性研究
该多中心可行性研究分析58例确诊COVID-19并接受初始低剂量胸部CT的患者,以腰围与椎旁肌周长比(FMR)估算体成分。结果显示需ICU治疗者初始FMR显著更高,多因素logistic回归中FMR(p<.001)与年龄(p<.01)均为需ICU治疗的显著预测因素。
要点
- 初始低剂量胸部CT可机会性测量FMR(腰围/椎旁肌周长比),用于评估体成分和肥胖。
- 随访22天内需ICU治疗的COVID-19患者,初始CT的FMR显著更高。
- 多因素分析中FMR(p<.001)和年龄(p<.01)是需ICU治疗的显著预测因素。
关键影像表现/征象
- 初始低剂量胸部CT显示,随访期间需ICU治疗的患者FMR显著更高。
- FMR基于腰围与椎旁肌周长的比值估算,用于反映体成分和肥胖。
诊断标准与关键数值
- 多因素logistic回归分析中,FMR预测COVID-19患者需ICU治疗的p<.001。
- 多因素logistic回归分析中,年龄预测COVID-19患者需ICU治疗的p<.01。
- 结局按序数量表评定,数值越高代表随访22天内病情进展或疾病相关并发症越严重(住院/ICU/气管插管/死亡)。
临床应用与阅片要点
- 作者指出,该多中心先导研究提出一种方法,利用初始低剂量胸部CT机会性筛查肥胖患者,这些患者需ICU治疗的风险增加。
- 作者指出,在ICU床位和呼吸机等临床资源比以往更关键之际,本方法可用于以成本效益方式帮助确定近期所需这些稀缺临床资源的数量。
局限性
- 原文称本研究为多中心先导研究(pilot study)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat to muscle area, measured in initial LDCT, can predict severe progression of COVID-19 in the follow-up period.
METHOD: We analyzed 58 individuals with confirmed COVID-19 infection that underwent an initial LDCT in one of two included centers due to COVID-19 infection. Using the ratio of waist circumference per paravertebral muscle circumference (FMR), the body composition was estimated. Patient outcomes were rated on an ordinal scale with higher numbers representing more severe progression or disease associated complications (hospitalization/ intensive care unit (ICU)/ tracheal intubation/ death) within a follow-up period of 22 days after initial LDCT.
RESULTS: In the initial LDCT a significantly higher FMR was found in patients requiring intensive care treatment within the follow-up period. In multivariate logistic regression analysis, FMR (p < .001) in addition to age (p < .01), was found to be a significant predictor of the necessity for ICU treatment of COVID-19 patients.
CONCLUSION: FMR as potential surrogate of body composition and obesity can be easily determined in initial LDCT of COVID-19 patients. Within the multivariate analysis, in addition to patient age, low muscle area in proportion to high fat area represents an additional prognostic information for the patient outcome and the need of an ICU treatment during the follow-up period within the next 22 days. This multicentric pilot study presents a method using an initial LDCT to screen opportunistically for obese patients who have an increased risk for the need of ICU treatment. While clinical capacities, such as ICU beds and ventilators, are more crucial than ever to help manage the current global corona pandemic, this work introduces an approach that can be used for a cost-effective way to help determine the amount of these rare clinical resources required in the near future.
引用
- Kottlors J, Zopfs D, Fervers P, et al. Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study. Eur J Radiol. 2020. PMID: 32961451. doi:10.1016/j.ejrad.2020.109274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。